Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Biomed Res Int ; 2013: 215283, 2013.
Article in English | MEDLINE | ID: mdl-23555077

ABSTRACT

Defence against Leishmania depends upon Th1 inflammatory response and, a major problem in susceptible models, is the turnoff of the leishmanicidal activity of macrophages with IL-10, IL-4, and COX-2 upregulation, as well as immunosuppressive PGE2, all together inhibiting the respiratory burst. Peroxisome proliferator-activated receptors (PPAR) activation is responsible for macrophages polarization on Leishmania susceptible models where microbicide functions are deactivated. In this paper, we demonstrated that, at least for L. mexicana, PPAR activation, mainly PPAR γ , induced macrophage activation through their polarization towards M1 profile with the increase of microbicide activity against intracellular pathogen L. mexicana. PPAR activation induced IL-10 downregulation, whereas the production of proinflammatory cytokines such as TNF- α , IL-1 ß , and IL-6 remained high. Moreover, PPAR agonists treatment induced the deactivation of cPLA2-COX-2-prostaglandins pathway together with an increase in TLR4 expression, all of whose criteria meet the M1 macrophage profile. Finally, parasite burden, in treated macrophages, was lower than that in infected nontreated macrophages, most probably associated with the increase of respiratory burst in these treated cells. Based on the above data, we conclude that PPAR agonists used in this work induces M1 macrophages polarization via inhibition of cPLA2 and the increase of aggressive microbicidal activity via reactive oxygen species (ROS) production.


Subject(s)
Cyclooxygenase 2/metabolism , Group IV Phospholipases A2/metabolism , Leishmania mexicana/metabolism , Leishmaniasis, Diffuse Cutaneous/metabolism , PPAR gamma/metabolism , Animals , Cells, Cultured , Cyclooxygenase 2/genetics , Cyclooxygenase 2 Inhibitors/pharmacology , Dinoprostone/metabolism , Group IV Phospholipases A2/genetics , Humans , Intramolecular Oxidoreductases/metabolism , Leishmania mexicana/drug effects , Leishmania mexicana/pathogenicity , Leishmaniasis, Diffuse Cutaneous/genetics , Leishmaniasis, Diffuse Cutaneous/parasitology , Macrophages/metabolism , Mice , PPAR gamma/agonists , PPAR gamma/genetics , Prostaglandin-E Synthases , Reactive Oxygen Species/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...